The future of TKIs in cancer treatment looks promising with ongoing research focused on identifying new targets and developing more potent inhibitors. Personalized medicine, where treatment is tailored based on the genetic makeup of an individual's cancer, is becoming increasingly feasible. The integration of TKIs with other treatment modalities, such as immunotherapy, is also being explored to enhance their efficacy.
